Harnessing Science, Technology, and Innovation to Combat Diabetes and Alleviate Poverty: An In Silico Approach to Natural Alpha-Amylase Inhibitors

Authors

  • G. Sony Assistant professor, Department of Biochemistry, St. Francis college for Women, Hyderabad, India Author
  • P. Josthna Professor, Department of Biotechnology, Sri Padmavathi Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, India Author

Keywords:

Alpha-Amylase Inhibitors, Diabetes Mellitus, In Silico Docking, Molecular Docking, Pterocarpus Santalinus, Trimetrexate

Abstract

Diabetes mellitus is a chronic metabolic disorder marked by hyperglycemia due to impaired insulin secretion or action, often leading to serious complications such as organ damage.While modern drugs like sulfonylureas and biguanides are widely used, they frequently cause adverse effects, prompting interest in safer, plant-based alternatives. α-Amylase inhibitors from medicinal plants are particularly important, as they can reduce glucose absorption. Computational chemistry, especially molecular docking, provides a cost-effective and efficient approach to drug discovery by predicting protein–ligand interactions, binding affinity, and inhibitory potential. In this study, phytochemicals from Pterocarpus santalinus, particularly Trimetrexate, were evaluated using molecular docking. Docking with human pancreatic α-amylase (PDB: 3OLD) and DPP-IV (PDB: 5Y7H) revealed that Trimetrexate showed strong binding affinities (–10.58 kcal/mol and –9.45 kcal/mol, respectively), surpassing standard drugs like Glibenclamide and Acarbose. SwissADME analysis confirmed favorable drug-like properties, including solubility, bioavailability, and absorption. These results suggest that Pterocarpus santalinus could be a valuable source for developing safer, low-cost therapies against Type 2 Diabetes Mellitus. The integration of science, technology, and innovation (STI) is crucial in tackling such health challenges. Computational tools like molecular docking accelerate drug discovery and reduce costs, making therapies more affordable. By combining medicinal plants and modern technology, accessible treatments can be developed to benefit low-income populations disproportionately affected by diabetes. Thus, the fusion of scientific research, technological innovation, and traditional knowledge can improve healthcare and contribute to poverty alleviation, supporting sustainable development goals.

References

[1] Gholap, N., Davies, M., Patel, K., Sattar, N., & Khunti, K. (2011). Type 2 diabetes and cardiovascular disease in South Asians. Primary Care Diabetes, 5(1), 45–56. https://doi.org/10.1016/j.pcd.2010.12.002

[2] Surya, S., Salam, A. D., Tomy, D. V., Carla, B., Kumar, R. A., & Sunil, C. (2014). Diabetes mellitus and medicinal plants—a review. Asian Pacific Journal of Tropical Disease, 4(5), 337–347. https://doi.org/10.1016/S2222-1808(14)60603-1

[3] David, L., Arús-Pous, J., Karlsson, J., Engkvist, O., Bjerrum, E. J., Kogej, T., Kriegl, J. M., Beck, B., & Chen, H. (2019). Applications of deep learning in exploiting large-scale and heterogeneous compound data in industrial pharmaceutical research. Frontiers in Pharmacology, 10, Article 1306. https://doi.org/10.3389/fphar.2019.01306

[4] Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B

[5] Guha, R., Howard, M. T., Hutchison, G. R., Murray-Rust, P., Rzepa, H., Steinbeck, C., Wegner, J., & Willighagen, E. L. (2006). The Blue Obelisk—Interoperability in chemical informatics. Journal of Chemical Information and Modeling, 46(3), 991–998. https://doi.org/10.1021/ci060031d

[6] Laurie, A. T., & Jackson, R. M. (2005). An energy-based method for the prediction of protein-ligand binding sites. Q-SiteFinder Bioinformatics, 21, 1908–1916. https://doi.org/10.1093/bioinformatics/bti288

[7] Utomo, D. H., Widodo, N., & Putri, R. K. (2012). Identification of potential inhibitors of hemagglutinin of H1N1 influenza virus from Indonesian medicinal plants by molecular docking analysis. Bioinformation, 8(9), 426–429. https://doi.org/10.6026/97320630008426

[8] Bikadi, Z., & Hazai, E. (2009). Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. Journal of Cheminformatics, 1(1), 15. https://doi.org/10.1186/1758-2946-1-15

Downloads

Published

01-10-2025

How to Cite

Harnessing Science, Technology, and Innovation to Combat Diabetes and Alleviate Poverty: An In Silico Approach to Natural Alpha-Amylase Inhibitors. (2025). GAMANAM: Global Advances in Multidisciplinary Applications in Next-Gen And Modern Technologies, 1(4), 199-215. https://gamanamspmvv.in/index.php/gamanams/article/view/50